2019 is almost over, and while some investors are reflecting on a successful year, others are scrambling to add value to their portfolio before the year wraps up. If you didn’t capitalize on the stock ... [Read]
REAL stock has been tanking this week after The RealReal Inc (NASDAQ:REAL) was accused of selling counterfeit goods on the luxury item marketplace. Authenticity Concerns Weigh on REAL Stock REAL shares have dropped over 20% ... [Read]
Many biotech stocks have recorded highly impressive gains this month so far, and one of the notable outperformers in November has been MYOV stock. So, what did Myovant Sciences (NYSE:MYOV) do to elicit this gain? ... [Read]
With the markets closing at all-time highs this week, would-be investors are eagerly looking out for the next penny stock that could make them a fortune in a very short period of time. Penny stocks ... [Read]
The natural gas sector has had a fairly impressive year so far but the same cannot be said about Chesapeake Energy Corporation (NYSE:CHK). The company has gone through its fair share of troubles, and CHK ... [Read]
ANF stock is recovering today after dropping earlier this week following Abercrombie & Fitch’s (NYSE:ANF) earnings report, which fell short of analysts’ expectations. Earnings Disappointment For the period ended October 31, Abercrombie & Fitch reported ... [Read]
Over the course of the past week or so, HEPA stock has been in the middle of a tearing rally and it is due to a major announcement made by Hepion Pharmaceuticals Inc (NASDAQ:HEPA) on ... [Read]
When discussing the technology of the future—the tech that’s bound to disrupt a given market—we so often think of software. We’ve grown accustomed to thinking of programs and algorithms as the next great way to ... [Read]
Penny stocks are those priced under $5, and they can often be very risky plays, but some investors love them. The chance to turn a minimal investment into a major return can often be too ... [Read]
CCXI stock is witnessing its biggest one-day gain after ChemoCentryx Inc (NASDAQ:CCXI) announced positive topline data from its pivotal Phase III ADVOCATE trial for avacopan. Dream Run for CCXI Stock When a pharmaceutical company announces ... [Read]